Study finds no link between diabetes drug rosiglitazone and increased rate of heart attack
Tuesday, June 29, 2010 - 11:07
in Health & Medicine
The diabetes drug rosiglitazone has been under intense scrutiny since a 2007 study in the New England Journal of Medicine looked at more than 40 clinical trials and linked the drug's use with increased risk of heart attack and death from heart disease.